| pubmed-article:7828139 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0194037 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0205851 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0020823 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C2931618 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C1328050 | lld:lifeskim |
| pubmed-article:7828139 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:7828139 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:7828139 | pubmed:dateCreated | 1995-2-17 | lld:pubmed |
| pubmed-article:7828139 | pubmed:abstractText | A Phase I-II trial to assess the toxicity and efficacy of a tandem high dose chemotherapy combining ifosfamide, carboplatin, and etoposide in germ cell tumors and metastatic trophoblastic disease was performed. | lld:pubmed |
| pubmed-article:7828139 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7828139 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7828139 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7828139 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:7828139 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7828139 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7828139 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7828139 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7828139 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:7828139 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:IzraelVV | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:DonsimoniRR | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:FirminCC | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:GerotaJJ | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:MeradZZ | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:LotzJ PJP | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:EstesoAA | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:BouleucCC | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:AndréTT | lld:pubmed |
| pubmed-article:7828139 | pubmed:author | pubmed-author:BonnacPP | lld:pubmed |
| pubmed-article:7828139 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7828139 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:7828139 | pubmed:volume | 75 | lld:pubmed |
| pubmed-article:7828139 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7828139 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7828139 | pubmed:pagination | 874-85 | lld:pubmed |
| pubmed-article:7828139 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:meshHeading | pubmed-meshheading:7828139-... | lld:pubmed |
| pubmed-article:7828139 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7828139 | pubmed:articleTitle | High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. | lld:pubmed |
| pubmed-article:7828139 | pubmed:affiliation | Department of Medical Oncology, Hospital St-Louis, Paris, France. | lld:pubmed |
| pubmed-article:7828139 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7828139 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7828139 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:7828139 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:7828139 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7828139 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7828139 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7828139 | lld:pubmed |
